Issuer news

Pentixapharm Releases Interim Report for the Third Quarter of 2024 Loss of Pentixapharm Holding AG for the reporting period: €49k No revenue realized during the stub fiscal year t…

DATRON AG publishes consolidated financial figures for the first 9 months of the 2024 financial year (German only) Umsatz TEUR 45.397 (Vorjahreswert TEUR 47.025) Auftragseingang T…

US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor 29.10.2024 / 11:46 CET Berlin and Würzburg, Germany, October 29, 2024 – The National Cancer Institute (…

New offering for business mail now comes from the cloud – Digital transformation in output management (German only) 22.10.2024 / 09:30 CET Neues Produkt Binect ONE basiert a…

EMA Grants PRIME Status to Pentixapharm’s Lead Candidate PentixaFor 18-Oct-2024 / 15:49 CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 5…

stock3 AG publishes half-year report 2024 (German only) 07.10.2024 / 11:29 CEST Ungeprüfte Umsatzerlöse in Höhe von EUR 6,4 Mio. Ungeprüftes EBITDA bei EUR 0,5 Mio. und deutlich ü…

Pentixapharm Holding AG Completes IPO in the Prime Standard of the Frankfurt Stock Exchange 03.10.2024 / 11:58 CET/CEST ADVERTISEMENT NOT FOR DISTRIBUTION OR ANNOUNCEMENT, DIRECTL…